These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 2243441)
41. Independent prognostic value of hormone receptor expression and S-phase fraction in advanced breast cancer. Pinto AE; Mendonça E; André S; Nóbrega SD; Soares J Anal Quant Cytol Histol; 2002 Dec; 24(6):345-54. PubMed ID: 12508694 [TBL] [Abstract][Full Text] [Related]
42. DNA flow cytometry but not telomerase activity as predictor of disease-free survival in pT1-2/N0/G2 breast cancer. Pinto AE; André S; Pereira T; Silva G; Soares J Pathobiology; 2006; 73(2):63-70. PubMed ID: 16943686 [TBL] [Abstract][Full Text] [Related]
43. DNA ploidy, S-phase fraction and mitotic indices as prognostic predictors of female breast cancer. Lipponen P; Papinaho S; Eskelinen M; Klemi PJ; Aaltomaa S; Kosma VM; Marin S; Syrjänen K Anticancer Res; 1992; 12(5):1533-8. PubMed ID: 1444217 [TBL] [Abstract][Full Text] [Related]
44. DNA content and S-phase fraction in male breast carcinomas. Hatschek T; Wingren S; Carstensen J; Hultborn R Acta Oncol; 1994; 33(6):609-13. PubMed ID: 7946436 [TBL] [Abstract][Full Text] [Related]
45. Ki-67 immunoreactivity, ploidy and S-phase fraction as prognostic factors in patients with gastric carcinoma. Victorzon M; Roberts PJ; Haglund C; von Boguslawsky K; Nordling S Oncology; 1996; 53(3):182-91. PubMed ID: 8643219 [TBL] [Abstract][Full Text] [Related]
46. Reappraisal of internal mammary node metastases as a prognostic factor in patients with breast cancer. Noguchi M; Ohta N; Koyasaki N; Taniya T; Miyazaki I; Mizukami Y Cancer; 1991 Nov; 68(9):1918-25. PubMed ID: 1655229 [TBL] [Abstract][Full Text] [Related]
47. S-phase fraction and DNA ploidy in 633 T1T2 breast cancers: a standardized flow cytometric study. Chassevent A; Jourdan ML; Romain S; Descotes F; Colonna M; Martin PM; Bolla M; Spyratos F Clin Cancer Res; 2001 Apr; 7(4):909-17. PubMed ID: 11309341 [TBL] [Abstract][Full Text] [Related]
48. Flow cytometric DNA ploidy defines patients with poor prognosis in node-negative breast cancer. Balslev I; Christensen IJ; Rasmussen BB; Larsen JK; Lykkesfeldt AE; Thorpe SM; Rose C; Briand P; Mouridsen HT Int J Cancer; 1994 Jan; 56(1):16-25. PubMed ID: 8262673 [TBL] [Abstract][Full Text] [Related]
49. DNA ploidy and percent S-phase as prognostic factors in node-positive breast cancer: results from patients enrolled in two prospective randomized trials. Witzig TE; Ingle JN; Schaid DJ; Wold LE; Barlow JF; Gonchoroff NJ; Gerstner JB; Krook JE; Grant CS; Katzmann JA J Clin Oncol; 1993 Feb; 11(2):351-9. PubMed ID: 8426213 [TBL] [Abstract][Full Text] [Related]
50. Prognostic value of DNA ploidy and S-phase fraction in stage I endometrial carcinoma. Pfisterer J; Kommoss F; Sauerbrei W; Rendl I; Kiechle M; Kleine W; Pfleiderer A Gynecol Oncol; 1995 Aug; 58(2):149-56. PubMed ID: 7622098 [TBL] [Abstract][Full Text] [Related]
51. The relationship of estrogen receptor status to DNA ploidy in breast cancer. Tsuchiya A; Nihei M; Ando Y; Suzuki S; Kimijima I; Abe R Surg Today; 1992; 22(2):105-9. PubMed ID: 1498488 [TBL] [Abstract][Full Text] [Related]
52. Flow cytometric DNA analysis as prognostic factor in human breast carcinoma. Ottestad L; Pettersen EO; Nesland JM; Hannisdal E; Fosså SD; Tveit KM Pathol Res Pract; 1993 May; 189(4):405-10. PubMed ID: 8351241 [TBL] [Abstract][Full Text] [Related]
53. Interrelations between cellular DNA content, S-phase fraction, hormone receptor status and age in primary breast cancer. A series of 1,342 consecutively detected tumors. South-East Sweden Breast Cancer Group. Stål O; Brisfors A; Carstensen J; Ferraud L; Hatschek T; Nordenskjöld B Acta Oncol; 1992; 31(3):283-92. PubMed ID: 1622647 [TBL] [Abstract][Full Text] [Related]
54. DNA ploidy is an independent predictor of survival in breast invasive ductal carcinoma: a long-term multivariate analysis of 393 patients. Pinto AE; Pereira T; Santos M; Branco M; Dias A; Silva GL; Ferreira MC; André S Ann Surg Oncol; 2013 May; 20(5):1530-7. PubMed ID: 23250736 [TBL] [Abstract][Full Text] [Related]
55. The prognostic information of DNA ploidy and S-phase fraction may vary with histologic grade in endometrial carcinoma. Gudmundsson TE; Högberg T; Alm P; Anderson H; Baldetorp B; Fernö M; Långström E; Killander D Acta Oncol; 1995; 34(6):803-12. PubMed ID: 7576749 [TBL] [Abstract][Full Text] [Related]
56. Prognostic value of S-phase fraction in lymph-node-negative breast cancer by image and flow cytometric analysis. Peiró G; Lerma E; Climent MA; Seguí MA; Alonso MC; Prat J Mod Pathol; 1997 Mar; 10(3):216-22. PubMed ID: 9071729 [TBL] [Abstract][Full Text] [Related]
57. Correlation of flow cytometry to clinical factors, hormone receptors, and histopathological grade in stage I and II invasive breast carcinoma. Haghbin M; McCue PA; Mansfield CM; Komarnicky LT; Benammar A; Schwartz GF Am J Clin Oncol; 1996 Feb; 19(1):54-8. PubMed ID: 8554037 [TBL] [Abstract][Full Text] [Related]
58. DNA index, S-phase fraction, histological grade and prognosis in breast cancer. O'Reilly SM; Camplejohn RS; Barnes DM; Millis RR; Allen D; Rubens RD; Richards MA Br J Cancer; 1990 May; 61(5):671-4. PubMed ID: 2159768 [TBL] [Abstract][Full Text] [Related]
59. [Flow cytophotometry parameters, hormone receptors and axillary lymph node status as prognostic factors in primary breast cancer]. Kaufmann M; Feichter GE; Nhila A; Klinga K; Abel U Geburtshilfe Frauenheilkd; 1988 Oct; 48(10):705-9. PubMed ID: 3234702 [TBL] [Abstract][Full Text] [Related]
60. DNA ploidy and survival in breast cancer patients. Cornelisse CJ; van de Velde CJ; Caspers RJ; Moolenaar AJ; Hermans J Cytometry; 1987 Mar; 8(2):225-34. PubMed ID: 3582068 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]